Next report date
Report period
Q1 2024
EPS estimate
−7.28MXN
Revenue estimate
157.11 MMXN
2.25 BMXN
4.25 BMXN
44.42 M
Om Voyager Therapeutics, Inc.
Sektor
Bransch
VD
Alfred W. Sandrock
Webbplats
Huvudkvarter
Lexington
Employees (FY)
162
Grundat
2013
FIGI
BBG00PGH1JJ6
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
